- 09/13/11Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD2011
- 09/08/11Alkermes Announces Shareholder Vote in Favor of Merger with Elan Drug Technologies
- 09/07/11Alkermes' Corporate Presentation to be Webcast at Two Upcoming Conferences
- 08/31/11Alkermes' Corporate Presentation to Be Webcast at Baird's 2011 Health Care Conference
- 08/10/11BYDUREON™ FDA Action Date Set For January 28, 2012
- 08/01/11Alkermes Reports First Quarter Fiscal 2012 Financial Results
- 07/28/11BYDUREON™ Reply Submitted to FDA
You are now leaving Alkermes.com.